Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
2022 Canadian Cardiovascular Society guideline for use of GLP-1 receptor agonists and SGLT2 inhibitors for cardiorenal risk reduction in adults
Semaglutide works by mimicking the action of the hormone GLP-1 in the body
This isn't a better Viagra
Semaglutide pharmacology & regulatory considerations
Community Experiences: Real-World Reports The Microdosing Movement Online communities have emerged around GLP-1 microdosing: Reddit r/Peptides: 1,700+ members discussing microdosing strategies Facebook groups: Multiple private groups with thousands of members TikTok trends: #GLP1Hack videos with millions of views Discord servers: Real-time support and protocol sharing Reported Motivations 66% Side effect reduction 38% Cost savings 28% Better control of blood sugar Common Protocols Reported While not medically validated, community members report using: Monday/Thursday: Twice-weekly splitting for convenience Monday/Wednesday/Friday: Three times weekly for stability Every other day: Maximum smoothing of levels Variable dosing: Higher doses on less active days Concerning Trends Problematic behaviors observed: 55% make decisions without physician consultation Many use compounded medications of uncertain quality Dose escalation beyond FDA-approved limits Combining multiple GLP-1 agonists Following influencer protocols without medical oversight A Personal Perspective When I started reading the reta research, one thing bugged me: this triple-agonist mechanism is far more complex than semaglutide, yet the dosing protocol is identical: once weekly, same as everything else
some are shorter
